Teladoc Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Teladoc Health reported a 4% revenue decrease in Q2 2026, driven by a strategic shift in its BetterHelp segment towards insurance-covered services, impacting overall financial performance.
NYSE
Teladoc Health reports a 2% revenue decrease for Q3 2025, alongside significant goodwill impairments and a net loss, despite growth in U.S. Integrated Care members.
NYSE
10-Q: Teladoc Health Reports Reduced Net Loss Amidst Mixed Segment Performance and Strategic Acquisitions
Teladoc Health, a global leader in virtual care, reported a significantly reduced net loss for the second quarter and first half of 2025, primarily due to lower goodwill impairment charges, despite a slight decline in overall revenue driven by its BetterHelp segment.
NYSE
Teladoc Health's Q1 2025 revenue decreased by 3% year-over-year, impacted by BetterHelp performance and a significant goodwill impairment charge.
NYSE
Teladoc Health's Q3 2024 results show a slight revenue decrease and a significant goodwill impairment charge, impacting overall profitability.
NYSE
Teladoc Health's Q2 2024 results reveal a significant $790 million goodwill impairment charge, impacting overall profitability despite some revenue growth in the Integrated Care segment.
NYSE
Teladoc Health's first quarter results show a slight revenue increase but a widening net loss, alongside a CEO departure and restructuring efforts.